Advertisement

Topics

Samsung Biologics to provide CDMO support for ‘bio-venture’ firm GI Innovation

11:26 EDT 9 May 2019 | Outsourcing-Pharma

Samsung Biologics is providing contract development services for GI Innovationâs pipeline, with the first among five molecules to initiate development immediately, says company representative.

Original Article: Samsung Biologics to provide CDMO support for ‘bio-venture’ firm GI Innovation

NEXT ARTICLE

More From BioPortfolio on "Samsung Biologics to provide CDMO support for ‘bio-venture’ firm GI Innovation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...